Researchers of the University of Pittsburgh from the School of Medicine department reported a potential immunization against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. At the point when tried in mice, the immunization, conveyed through a fingertip-sized fix, produces antibodies explicit to SARS-CoV-2 at amounts thought to be adequate for killing the Chinese Virus or widely known as the corona Virus.According to University of Pittsburgh Press Release and Reliable Sources
The paper showed up April 2 in e biomedicine, which is distributed by The Lancet and is the main Article to be distributed after investigating from individual researchers at outside organizations that depicts an applicant antibody for COVID-19. The analysts had the option to act rapidly on the grounds that they had just laid the foundation during the prior corona virus (COVID 19 / Chinese Virus) epidemics.
What is COVID 19 Disease or Chinese Virus (Corona Virus)?
Coronavirus sickness (COVID-19) is an irresistible malady brought about by a newfound coronavirus. As you probably are aware another respiratory infection called COVID-19 is spreading over the world.
A great many people tainted with the COVID-19 infection otherwise called the Chinese Virus (Corona Virus) will encounter mellow to direct respiratory disease and recuperate without requiring unique treatment. More established individuals and those with basic clinical issues like cardiovascular sickness, diabetes, incessant respiratory malady, and malignant growth are bound to create genuine ailment.
COVID-19 is a disease caused by the “novel corona virus”. About 90% of confirmed cases recover from the disease without any serious complications. However, one out of every six people who get COVID-19 can become seriously ill* and develop difficulty in breathing. In more severe cases, the infection can cause severe pneumonia and other complications that can be treated only at higher-level facilities (District Hospitals and above). In a few cases, it may even cause death.
How does Corona Virus Spread?
COVID-19 (Coronavirus) spreads mainly by droplets produced as a result of coughing or sneezing of a COVID-19 or Chinese Virus-infected person. This can happen in two ways:
- Direct close contact:- You’ll be able to get the contamination through being in close contact with COVID-19 sufferers or patient (inside one meter of the inflamed man or woman), in particular, if they do not cover their face whilst coughing or sneezing.
- Indirect contact:- The droplets survive on surfaces and clothes for many days. Therefore, touching any such infected surface or cloth and then touching one’s mouth, nose or eyes can transmit the disease.
Prevention Is The Best Cure
To prevent infection and to slow transmission of COVID-19, do the following:
- Wash your hands regularly with soap and water, or clean them with alcohol-based hand rub.
- Maintain at least 1 meter distance between you and people coughing or sneezing.
- Avoid touching your face.
- Cover your mouth and nose when coughing or sneezing.
- Stay home if you feel unwell.
- Refrain from smoking and other activities that weaken the lungs.
- Practice physical distancing by avoiding unnecessary travel and staying away from large groups of people.
Successful Research on COVID 19 Treatment
“We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014. These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus. We knew exactly where to fight this new virus. That’s why it’s important to fund vaccine research. You never know where the next pandemic will come from.Co-senior author Andrea Gambotto, associate professor of surgery at the Pitt School of Medicine
The paper appeared April 2 in eBioMedicine, which is published by The Lancet, and is the first study to be published after critique from fellow scientists at outside institutions that describes a candidate vaccine for COVID-19. The researchers were able to act quickly because they had already laid the groundwork during earlier corona virus epidemics.
Our ability to rapidly develop this vaccine as a result of scientists with expertise in diverse areas of research working together with a common goal.Louis Falo, professor and chair of dermatology at Pitt’s School of Medicine and UPMC
Compared to the experimental mRNA vaccine candidate that just entered clinical trials, the vaccine described in this paper—which the authors are calling PittCoVacc, short for Pittsburgh Corona Virus Vaccine—follows a more established approach, using lab-made pieces of viral protein to build immunity. It’s the same way the current flu shots work.
The researchers also used a novel approach to deliver the med, called a microneedle array, to increase potency. This array is a fingertip-sized patch of 400 tiny needles that deliver the spike protein pieces into the skin, where the immune reaction is strongest. The patch goes on like a Band-Aid and then the needles—which are made entirely of sugar and the protein pieces—simply dissolve into the skin.
We developed this to build on the original scratch method used to deliver the smallpox vaccine to the skin, but as a high-tech version that is more efficient and reproducible patient to patient, And it’s actually pretty painless—it feels kind of like Velcro.Louis Falco, M.D., Ph.D., Professor & Chair of Dermatology, Pitt School of Medicine & UPMC